Occurrence of a T Cell Lymphoma in a Patient with Chronic Myeloid Leukemia Treated with Alpha Interferon

References

• Fauser A. A., Kanz L., Bross K. Y., Lohr G. W. T cells and probably B cells arise from the malignant clone in chronic myelogenous leukemia. J. Clin. Invest. 1985; 75: 1080–1082
   PubMed Web of Science ®Google Scholar
• Hermann F., Ludwig W. D., Kolecki P. Blast crisis in CML showing early T lymphoblastic transformation. Br. J. Haematol. 1984; 56: 175–182
   PubMed Web of Science ®Google Scholar
• Jacobs P., Greaves M. F. Phi positive T-lymphoblastic transformation leukemia. Res. 1984; 8: 737–741
   Google Scholar
• Montefuso E., Maaro F. R., Lococo F., Rondinelli B., Arcese W., Monabca A., Tabilio B., Aumena G., Mandelli F. Long term remission of T lymphoid extramedullary blast crisis of chronic myelogenous leukemia following allogenic bone marrow transplantation. Haematologica 1990; 75: 391–393
   PubMedGoogle Scholar
• Leone G., La Rocca L. M., Teofili L., De Candia E., Landolfi R., Sica S., Zollino M., Tabilio A. Lymph node blast crisis in chronic myeloid leukemia mimicking T immunoblastic lymphoma. Haematologica 1992; 77: 311–314
   PubMedGoogle Scholar
• Vannier J. P., Bizet M., Bastard C., Bernard A., Ducastell T. H., Tron P. Simultaneous occurence of T cell lymphoma and a chronic myelogenous leukemia with an unusual karyotype. Leuk. Res. 1984; 8: 647–657
   PubMed Web of Science ®Google Scholar
• Djulbecovic B., Hadley Y., Yen F. Occurence of high grade T cell lymphoma in a patient with Philadelphia chromosome negative chronic myelogenous leukemia with breadkpoint cluster region rearrangement: case report and review of the litterature. Am J Hematol. 1991; 36: 63–64
   PubMed Web of Science ®Google Scholar
• Blonk M. C., Van Der Valk P., Beverstock G. C., Ossenkopele G. J. Sequential development of peripheral T cell lymphoma in the course of chronic myelogenous leukemia. Cancer 1990; 66: 1198–1203
   PubMed Web of Science ®Google Scholar
• Montefuso E., Lococo F., Leu O., Burgio V., Rondinelli B., Digiorgio G., Mancini M., Diverio D., Andriani A., Avvisati G., Alimena G. Occurence of a K-I-positive anaplastic large cell lymphoma in a patient with ph'positive chronic myelogenous leukemia successfully treated by alpha interferon. Leukemia 1993; 7(11): 1896–1899
   Web of Science ®Google Scholar
• Knecht H., Sarray A., Delacrettaz F., Bachmann E., Clement F. Genetypic and phenotypic evidence of T cell leukemia in a patient successfully treated by alpha-interferon for typical hairy cell leukemia. Leukemia 1991; 5(12)1031
   PubMed Web of Science ®Google Scholar
• Giardina S. L., Young H. A., Faltyned C. R., Jaffe S., Clard J. W., Steid R. G., Urba W. J., Mathieson B. J., Gralnick H., Lawrence J., Overton W. R., Longo P. L. Rearrangement of both immunoglobulin and T cell receptor genes in a prolymphocytic variant of a hairy cell leukemia patient resistant to interferon α. Blood 1988; 72: 1708–1716
   PubMed Web of Science ®Google Scholar
• Nakamuras Sushi T., Koshikawa T., Suruki H., Oyama A., Kojima M., Motoori T., Ueda R., Takahashi T. Clinicopathologie study of 212 cases of peripheral T-cell lymphoma among the Japanese. Cancer 1993; 72: 1762–1772
   PubMed Web of Science ®Google Scholar
• Jones J. F., Shurin S., Abrainwsky C., Sciotto R. R., Tubbs G, Wahl R. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infection. N. Engl. J. Med. 1988; 318: 733–741
   PubMed Web of Science ®Google Scholar
• Preston-Martin S., Thomas D. C., Vum C. Diagnostic radiographic as a risk factor for chronic myeloid and monocytic leukaemia (CML). Br. J. Cancer 1989; 59: 639
   PubMed Web of Science ®Google Scholar
• Duncombe A. S., Heslop H. E., Turner M., Meager A., Priest R., Exley T., Brenner M. K. Tumor necrosis factor mediates autocrine growth inhibition in a chronic leukemia. J. Immunol. 1989; 143(11): 3828–3834
   Web of Science ®Google Scholar
• Ranges C. E., Zlotnik A., Espevik T., Dlinarello C., Cerami A., Palladino M. Tumor necrosis factor a/cachectin is a growth factor for thymocytes. J. Exp. Med. 1988; 167: 1472–1478
   PubMed Web of Science ®Google Scholar
• Stiehm R. Interferon: Immunobiology and clinical significance. Ann. Int. Med. 1982; 96: 80–93
   PubMed Web of Science ®Google Scholar
• Knop J., Taborski R., De Maejer-Guignard T. Selective inhibition of the generation of T suppressor cells of contact sensitivity in vitro by interferon. J. Immunol. 1987; 138: 3684–3687
   PubMed Web of Science ®Google Scholar
• Sigaux F., Castaigne S., Lehn P., Dupuy E., Billard C., Boiron J. C., Gluckman M., Falcoff E., Flandrin G., Degos L. Alpha interferon in hairy cell leukemia; direct effects on hairy cells or indirect cytotoxicity. Int. J. Cancer 1987; Suppl 1: 2–8
   Google Scholar
• Remenieras L., Cransac M., Liozon E., Jauberteau M., Vidal E., Boressoule D. Auto-antibodies during alpha 2-b interferon (IFN) therapy for haematologic malignancies in 56 patients. 24th Cong. Int. Soc. Haematol, ISH, LondonUK, 1992; 23–27150, Dug
   Google Scholar
• Wandl U. B., Nagel-Hiemke M., May D., Klode O., Kreuzreldere Krazhoff M., Seeber S., Niederle N. Lupus like autoimmune disease induced by interferon therapy for myeloproliferative disorders. J. Clin. Immunopathol. 1992; 65(1): 70–74
   Web of Science ®Google Scholar